Easton Pharmaceuticals Inc., formerly LAM Industries, Inc, develops, markets and licenses wound healing and transdermally delivered drugs, therapeutic preparations and cosmetics for the prescription, over-the-counter and cosmetic markets, using its L.A.M. Ionic Polymer Matrix technology (L.A.M. IPM). The Company has one commercially available product, the L.A.M. IPM Wound Gel, a hydrogel used for wound healing. The L.A.M. IPM Wound Gel received approval from the United States Food and Drug Administration in April 2002, and was launched by L.A.M. in August 2002. All other potential products of the Company, which includes Post Surgical Matrix, Burn Matrix and products for female sexual dysfunction and dry skin, are in various stages of development and testing. In December 2009, the Company announced the acquisitions of Viorra Bio Medical Inc. and Ixora Bio Medical Company Inc.